Table 3. Hazard Ratios from Cox Regression Models for Baseline Troponin Assessed by Contemporary-Sensitivity, High-Sensitivity and Super-Sensitivity Assays for Various Endpoints after Adjustment for the Framingham Risk Score.
Continuous | Categorical | ||||
Event | Troponin | HR (95% CI) | p value | HR (95% CI) | p value |
MACE | cs-cTnI | 1.07 (0.97–1.17) | ns | 1.22 (0.95–1.57) | ns |
hs-cTnI | 1.12 (1.05–1.19) | <0.001 | 1.24 (0.91–1.69) | ns | |
ss-cTnI | 1.18 (1.11–1.25) | <0.001 | 2.10 (1.21–3.63) | 0.008 | |
CVD | cs-cTnI | 1.07 (0.96–1.20) | ns | 1.20 (0.87–1.64) | ns |
hs-cTnI | 1.09 (1.01–1.18) | 0.032 | 1.08 (0.74–1.58) | ns | |
ss-cTnI | 1.15 (1.07–1.24) | <0.001 | 1.95 (0.97–3.93) | ns | |
MI | cs-cTnI | 1.17 (0.10–1.39) | ns | 1.52 (0.90–2.57) | ns |
hs-cTnI | 1.17 (1.04–1.30) | 0.006 | 1.11 (0.59–2.10) | ns | |
ss-cTnI | 1.24 (1.11–1.39) | <0.001 | 2.85 (0.69–11.68) | ns | |
HF | cs-cTnI | 1.10 (0.96–1.26) | ns | 1.31 (0.90–1.89) | ns |
hs-cTnI | 1.19 (1.10–1.30) | <0.001 | 1.68 (1.04–2.72) | 0.036 | |
ss-cTnI | 1.28 (1.18–1.39) | <0.001 | 2.59 (1.15–5.82) | 0.02 | |
Stroke | cs-cTnI | 1.04 (0.86–1.26) | ns | 1.02 (0.63–1.65) | ns |
hs-cTnI | 1.09 (0.96–1.23) | ns | 0.99 (0.55–1.78) | ns | |
ss-cTnI | 1.14 (1.01–1.28) | 0.032 | 1.97 (0.64–6.09) | ns | |
Death | cs-cTnI | 1.03 (0.89–1.18) | ns | 1.04 (0.73–1.47) | ns |
hs-cTnI | 1.06 (0.98–1.14) | ns | 1.40 (0.96–2.05) | ns | |
ss-cTnI | 1.06 (0.98–1.15) | ns | 1.02 (0.64–1.64) | ns |
Shown are the hazard ratios for continuous troponin concentration per 1-SD increment and for categorical troponin concentration, comparing the highest with the lowest defined category. Please see the footnote to Table 2 for cut points of the categories.
Abbreviations: MACE = major adverse cardiac events, CVD = cardiovascular disease, MI = myocardial infarction, HF = heart failure, HR = hazard ratio, CI = confidence interval, cs-cTnI = troponin I measured by contemporary-sensitivity assay, hs-cTnI = highly sensitive troponin, ss-cTnI = supersensitive troponin, ns = not significant.